Concepedia

Publication | Open Access

Neridronate Prevents Bone Loss in Patients Receiving Androgen Deprivation Therapy for Prostate Cancer

DOIFull Paper Access

47

Citations

32

References

2004

Year

N. Morabito, Agostino Gaudio, Antonino Lasco, Antonino Catalano, Marco Atteritano, A Trifiletti, Giuseppina Anastasi, D. Melloni, N Frisina
Journal of Bone and Mineral Research

Abstract

Neridronate is an effective treatment in preventing bone loss in the hip and lumbar spine in men receiving ADT for prostate cancer.

References

YearCitations

Page 1